Colgate-Palmolive Company $CL Stock: Krilogy Financial LLC Raises Holdings

Krilogy Financial LLC boosted its position in Colgate-Palmolive Company (NYSE:CL) by 255.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,715 shares of the company’s stock after buying an additional 11,291 shares during the period. Krilogy Financial LLC’s holdings in Colgate-Palmolive were worth $1,341,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CL. State Street Corp boosted its holdings in Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after acquiring an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after acquiring an additional 1,010,872 shares during the period. First Eagle Investment Management LLC grew its stake in Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after acquiring an additional 88,917 shares during the period. Amundi increased its holdings in shares of Colgate-Palmolive by 19.9% during the second quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after acquiring an additional 1,033,918 shares in the last quarter. Finally, Bank of America Corp DE bought a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $567,483,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the sale, the director directly owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 over the last three months. Corporate insiders own 0.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a research report on Monday, August 3rd. BNP Paribas Exane decreased their price target on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, September 28th. Royal Bank Of Canada restated an “outperform” rating and set a $104.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, September 8th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $89.00 price objective (up from $88.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.95.

Colgate-Palmolive Stock Down 0.2%

Colgate-Palmolive stock opened at $92.61 on Friday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The firm’s 50-day simple moving average is $89.04 and its 200 day simple moving average is $88.99. The stock has a market cap of $73.82 billion, a PE ratio of 36.75, a price-to-earnings-growth ratio of 4.44 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same quarter last year, the business posted $0.92 EPS. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. Research analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is currently 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.